Bleakley Financial Group, LLC Compass Therapeutics, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.28 Trillion
- Q3 2024
A detailed history of Bleakley Financial Group, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 11,404 shares of CMPX stock, worth $17,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,404Holding current value
$17,334% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
79Shares Held
91.9MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$34 Million0.97% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$16.9 Million0.04% of portfolio
-
Blackstone Inc New York, NY10MShares$15.2 Million0.09% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$10.1 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA5.64MShares$8.58 Million1.62% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $154M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...